Vasopressin in septic shock: Pressing questions remain

Canadian Journal of Anesthesia

Volumn 56, Issue 1, 2009, Pages 80-82

  Keyes, Robert ^a   Brindley, Peter G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873952346     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-008-9009-2     Document Type: Article

References (9)

1. Angus D, Linde-Zwirble WT, Lidicker J, Clermond G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303-10. (Pubitemid 32641789)
2. Parrillo JE. Septic shock-vasopressin, norepinephrine, and urgency. N Engl J Med. 2008; 358: 954-6.
3. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001; 345: 588-95.
4. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001; 120: 989-1002. (Pubitemid 32885477)
5. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002; 96: 576-82. (Pubitemid 34193495)
6. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999; 47: 699-703.
7. Rivers E, Nguyen B, Havstad S. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345: 1368- 77.
8. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36: 296-327.
9. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34: 1589-96. (Pubitemid 43810035)